WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page 3 4 PRESS RELEASE DATED JANUARY 9, 2012]
[Form 6-K TABLE OF CONTENTS Page 3 4 PRESS RELEASE DATED JANUARY 9, 2012]
[Form 6-K TABLE OF CONTENTS Page 3 4 PRESS RELEASE DATED JANUARY 9, 2012]
[December 27, 2011 VIA EMAIL AND ELECTRONIC TRANSMISSION Mr. Jim B. Rosenberg Senior Assistant Chief Accountant Division of Corporation Finance Re: WuXi PharmaTech (Cayman) Inc. Form 20-F filed on April 27, 2011 (File No. 001-33623) Dear Mr. Rosenberg, Item 5. Operating and Financial Review and Prospects Results of Operations, page 48 1. The Company respectfully advises the Staff that]
[December 27, 2011 VIA EMAIL AND ELECTRONIC TRANSMISSION Mr. Jim B. Rosenberg Senior Assistant Chief Accountant Division of Corporation Finance Re: WuXi PharmaTech (Cayman) Inc. Form 20-F filed on April 27, 2011 (File No. 001-33623) Dear Mr. Rosenberg, Item 5. Operating and Financial Review and Prospects Results of Operations, page 48 1. The Company respectfully advises the Staff that]
[WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 Peoples Republic of China December 12, 2011 VIA EMAIL AND ELECTRONIC TRANSMISSION Division of Corporate Finance Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Re: WuXi PharmaTech (Cayman) Inc. Form 20-F filed on April 27, 2011 (File No. 001-33623) Dear Mr. Rosenberg: Comment Letter This]
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4 PRESS RELEASE DATED AUGUST 10, 2011]
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4 PRESS RELEASE DATED AUGUST 10, 2011]
[Form 6-K TABLE OF CONTENTS Page 3 4 2]